Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients
Table 1
Baseline characteristics of CKD stage 3–4, CKD stage 5-ESRD, and non-CKD groups.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Baseline characteristics of CKD stage 3–4, CKD stage 5-ESRD, and non-CKD groups.